A review of bile acid sequestrants: Potential mechanism(s) for glucose-lowering effects in type 2 diabetes mellitus

Postgraduate Medicine

Volumn 121, Issue 3, 2009, Pages

  Staels, Bart ^a,b  

^a UNIV LILLE   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Bile acid pool; Bile acid sequestrant; Colesevelam HCL; Glycemic control; Mechanism of action; Type 2 diabetes mellitus

Indexed keywords

BILE ACID; BILE ACID SEQUESTRANT; CHENODEOXYCHOLIC ACID; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLIC ACID; COLESEVELAM; COLESTYRAMINE; DEOXYCHOLIC ACID; FARNESOID X RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 4; GLUCAGON LIKE PEPTIDE 1; HEPATOCYTE NUCLEAR FACTOR 4; LIVER RECEPTOR HOMOLOG 1; URSODEOXYCHOLIC ACID;

BILE ACID SYNTHESIS; DRUG MECHANISM; ENTEROHEPATIC CIRCULATION; GLUCOSE ABSORPTION; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; REVIEW;

EID: 67649206289     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2009.05.suppl53.290     Document Type: Review

References (36)

1. Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Rote of bile acids and bile acid receptors in metabolic regulation. Physiol Rev. 2009;89(1):147-191.
2. Angelin B, Bjorkhem I, Einarsson K, Ewerth S. Hepatic uptake of bile acids us man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum. J Clin Invest. 1982;70(4):724-731. (Pubitemid 12038088)
3. Lu TT, Makishima M, Repa JJ, et al. Molecular basis for feedback regulation of bite acid synthesis by nuclear receptors. Mol Cell. 2000;6(3):507-515.
4. Houten SM, Auwerx J. The enterohepatic nuclear receptors are major regulators of the ersterohepatic circulation of bile salts. Ann Med. 2004;36(7):482-491. (Pubitemid 39490958)
5. Li-Hawkins J, Gafvels M, Olin M, et al. Cholic acid mediates negative feedback regulation of bilc acid synthesis in mice. J Clin Invest. 2002;110(8):1191-1200. (Pubitemid 35215900)
6. Nervi FO, Gonzalez A, Valdivieso VD. Studies on cholesterol metabolism in the diabetic rat. Metabolism. 1974;23(6):495-503.
7. Wey HE, Yunker RL, Harris P, Subbiah MT. Effect of streptozotocin-induced diabetes in neonatal rat on bile acid pool changes in adult life: selective sensitivity in females. Biochem Med. 1984;31(2):167-173. (Pubitemid 14133775)
8. Abrams JJ, Ginsberg H, Grundy SM. Metabolism of cholesterol and plasma triglycerides in nonketotic diabetes mellitus. Diabetes. 1982;31(10):903-910. (Pubitemid 12013795)
9. Andersen E, Hellstrom P, Hellstrom K. Cholesterol biosynthesis in nonketotic diabetics before and during insulin therapy. Diabetes Res Clin Pract. 1987;3(4):207-214. (Pubitemid 17092555)
10. Andersen E, Karlaganos G, Sjovall J. Altered bile acid profiles in duodenal bile and urine in diabetic subjects. Eur J Clin Invest. 1988;18(2):166-172. (Pubitemid 18188880)
11. Bennion LJ, Grundy SM. Effects of diabetes mellitus on cholesterol metabolism in man. N Engl J Med. 1977;296(24):1365-1371. (Pubitemid 8127337)
12. Brufau G, Kuipers F, Prado K, et al. Altered bile salt metabolism in type 2 diabetes mellitus (T2DM). Presented at: 68th Annual American Diabetes Association Scientific Sessions; June 6-10, 2008: San Francisco, CA.
13. Braunlin W, Zhorov E, Smisek D, et al. In vitro comparison of bile acid binding to colesevelam HCl and other bile acid sequestrants. Polymer Preprints. 2000;41(1):708-709.
14. Thomson AB, Keelan M. Feeding rats diets containing cheno- or ursodeoxycholic acid or cholestyramine modifies intestinal uptake of glucose and lipids. Digestion. 1987;38(3):160-170. (Pubitemid 18054707)
15. Watanabe M, Houten SM, Mataki C, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006;439(7075):484-489. (Pubitemid 43152840)
16. Reasner CA. Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors. J Cardiovasc Pharmacol. 2008;52(2):136-144.
17. Makishima M, Okamoto AY, Repa JJ, et al. Identification of a nuclear receptor for bile acids. Science. 1999;284(5418):1362-1365. (Pubitemid 29289663)
18. Parks DJ, Blanchard SG, Bledsoe RK, et al. Bile acids: natural ligands for an orphan nuclear receptor. Science. 1999;284(5418):1365-1368. (Pubitemid 29289664)
19. Wang H, Chen J, Hollister K, Sowers LC, Forman BM. Endocenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell. 1999;3(5):543-553. (Pubitemid 29268438)
20. Cariou B, Duran-Sandoval D, Kuipers F, Staels B. Farnesoid X receptor: a new player in glucose metabolism? Endocrinology. 2005;146(3):981-983.
21. Goodwin B, Jones SA, Price RR, et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell. 2000;6(3):517-526.
22. Goodwin B, Watson MA, Kim H, Miao J, Kemper JK, Kliewer SA. Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-alpha. Mol Endocrinol. 2003;17(3):386-394. (Pubitemid 36315633)
23. Yamagata K, Daitoku H, Shimamoto Y, et al. Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1. J Biol Chem. 2004;279(22):23158-23165. (Pubitemid 38685621)
24. Inoue Y, Yu AM, Yim SH, et al. Regulation of bile acid biosynthesis by hepatocyte nuclear factor 4alpha. J Lipid Res. 2006;47(1)215-227. (Pubitemid 43107464)
25. Zhang M, Chiang JY. Transcriptional regulation of the human sterol 12alpha-hydroxylase gene (CYP8B1): roles of hepatocyte nuclear factor 4alpha in mediating bile acid repression. J Biol Chem. 2001;276(45):41690-41699. (Pubitemid 37371062)
26. Fu L, John LM, Adams SH, et al. Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology. 2004;145(6):2594-2603. (Pubitemid 38686202)
27. Duran-Sandoval D, Mautino G, Martin G, et al. Glucose regulates the expression of the farnesoid X receptor in liver. Diabetes. 2004;53(4):890-898. (Pubitemid 38436600)
28. Kawamata Y, Fujii R, Hosoya M, et al. AG protein-coupled receptor responsive to bile acids. J Biol Chem. 2003;278(11):9435-9440. (Pubitemid 36800434)
29. Thomas C, Auwerx J, Schoonjans K. Bile acids and the membrane bile acid receptor TGR5 - connecting nutrition and metabolism. Thyroid. 2008;18(2):167-174. (Pubitemid 351271532)
30. Thomas C, Pellicciarì R, Pruzanski M, Auwerx J, Schoonjans K. Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov. 2008;7(8):678-693.
31. Katsuma S, Hirasawa A, Tsujimoto G. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Rev Commun. 2005;329(1):386-390. (Pubitemid 40255465)
32. Suzuki T, Oba K, Igari Y, et al. Colestimide lowers plasma glucose levels and increases plasma glucagon-like PEPTIDE-1 (7-36) levels in patients with type 2 diabetes mellitus complicated by hypercholesterolemia. J Nippon Med Sch. 2007;74(5):338-343.
33. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and rcsistance. Am J Physiol. 1979;237(3):E214- E223. (Pubitemid 9249478)
34. Schwartz SL, Abby SL, Lai YL, Xu J, Jones MR, Nagendran S. Effect of colesevelam HCl on postprandial glucose levels in subjects with type 2 diabetes mellitus. Presented at: 6th Annual World Congress on the Insulin Resistance Syndrome; September 25-27, 2008; Los Angeles, CA.
35. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22(9):1462-1470. (Pubitemid 29418240)
36. Forman BM, Lin M, Jones MR, Abby SL, Van Critters G. Culesevelam HCl affects gene expression in metabolic tissues in db/db mice. Presented at: 68th Annual American Diabetes Association Scientific Sessions; June 6-10, 2008; San Francisco, CA.